Norvegija -
norvegų -
Statens legemiddelverk
rimactazid 150 mg / 75 mg
sandoz - københavn - rifampicin / isoniazid - tablett, filmdrasjert - 150 mg / 75 mg
Norvegija -
norvegų -
Statens legemiddelverk
rimstar
sandoz - københavn - rifampicin / isoniazid / pyrazinamid / etambutolhydroklorid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg / 275 mg
Norvegija -
norvegų -
Statens legemiddelverk
sporanox 100 mg
janssen-cilag as - itrakonazol - kapsel, hard - 100 mg
Norvegija -
norvegų -
Statens legemiddelverk
kaleorid 750 mg
karo pharma ab - kaliumklorid - depottablett - 750 mg
Europos Sąjunga -
norvegų -
EMA (European Medicines Agency)
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
Europos Sąjunga -
norvegų -
EMA (European Medicines Agency)
kerendia
bayer ag - finerenone - renal insufficiency, chronic; diabetes mellitus, type 2 - agenter som virker på renin-angiotensinsystemet - kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.
Europos Sąjunga -
norvegų -
EMA (European Medicines Agency)
qaialdo
nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 og 5.
Europos Sąjunga -
norvegų -
EMA (European Medicines Agency)
aqumeldi
proveca pharma limited - enalapril (maleate) - hjertefeil - agenter som virker på renin-angiotensinsystemet - treatment of heart failure.
Norvegija -
norvegų -
Statens legemiddelverk
kaliumklorid eql pharma 750 mg
eql pharma ab - kaliumklorid - depottablett - 750 mg
Europos Sąjunga -
norvegų -
EMA (European Medicines Agency)
entresto
novartis europharm limited - sacubitril, valsartan - hjertefeil - angiotensin ii antagonister, andre kombinasjoner, agenter som handler på renin-angiotensin-systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.